DCE endometriosis

  • Research type

    Research Study

  • Full title

    Endometriosis-related pain Patient preference study

  • IRAS ID

    209877

  • Contact name

    Natalia Hawken

  • Contact email

    nha@creativ-ceutical.com

  • Sponsor organisation

    creativ-ceutical

  • Duration of Study in the UK

    0 years, 6 months, 17 days

  • Research summary

    The purpose of this study is to produce evidence on patient preferences related to medication attributes, among patients with endometriosis-related moderate to severe pain.

    The Discrete Choice Experiment (DCE) methodology will be used to explore the preferences of patients with endometriosis-related moderate to severe pain. The principle of the DCE is to determine a limited number of treatment characteristics, called attributes, which are expected to drive the preference between alternative forms of treatments. For each attribute, there will be two or more levels (e.g.: mode of administration: oral; intravenous; vaginal ring). We will then create combinations of attributes, designated as scenarios, representing fictitious treatments. Several pairs of scenarios will be presented to patients, who will be asked to indicate which scenario they prefer in each case. Using those data, we will be able to estimate the marginal utility associated with each attribute.
    We will include a cost attribute in the study so that willingness to pay could be used as a measure of the magnitude of preference associated with different characteristics.

  • REC name

    Yorkshire & The Humber - Leeds East Research Ethics Committee

  • REC reference

    16/YH/0421

  • Date of REC Opinion

    23 Sep 2016

  • REC opinion

    Unfavourable Opinion